Medicine and Dentistry
Apoplexy
100%
Brain Ischemia
77%
Atrial Fibrillation
47%
Patient
37%
Blood Pressure
22%
Cardiovascular System
19%
Cerebral Hemorrhage
18%
Odds Ratio
15%
Deterioration
15%
Systolic Blood Pressure
14%
Cerebral Atherosclerosis
13%
Brain Infarction
13%
Antithrombotic
11%
Cilostazol
10%
Infarction
10%
National Institutes of Health Stroke Scale
8%
Acetylsalicylic Acid
8%
Headache
8%
Hazard Ratio
7%
Arm
7%
Secondary Prevention
7%
Blood Clot Lysis
7%
Hypertension
7%
Triflusal
7%
CYP2C19
7%
Glycemic Load
7%
Diastolic Blood Pressure
7%
Therapeutic Procedure
7%
Atherosclerosis
7%
Association
7%
Combination Therapy
6%
Modified Rankin Scale
6%
Transient Ischemic Attack
6%
CHA2DS2-VASc Score
6%
Stenosis
5%
Odds Ratio
5%
Smoking
5%
High Density Lipoprotein Cholesterol
5%
Group Trial
5%
Analysis
5%
Post-Hoc Analysis
5%
Incidence
5%
Randomized Clinical Trial
5%
In Silico
5%
Heart Function
5%
Arterial Stiffness
5%
Ejection Fraction
5%
Gut
5%
Thrombogenicity
5%
Isotopes of Calcium
5%
Neuroscience
Brain Ischemia
67%
Cerebrovascular Accident
66%
Ischemic Stroke
41%
Atrial Fibrillation
36%
Stroke
30%
Atrial Fibrillation
26%
Blood Plasma
15%
Cerebral Hemorrhage
12%
Lacunar Stroke
10%
Stenosis
10%
Cerebral Infarction
10%
Omega 3 Fatty Acid
10%
Clopidogrel
10%
Antithrombotic
9%
Cilostazol
8%
Aspirin
8%
Cytochrome P450 2C19
7%
Docosahexaenoic Acid
6%
Hypertension
6%
Magnetic Resonance Imaging
6%
Fatty Acids
6%
Anticoagulant
5%
Stenosis
5%
Triflusal
5%
Obstructive Sleep Apnea
5%
Protein Bcl 2
5%
Caspase 3
5%
Antioxidant
5%
Headaches
5%
Apolipoprotein B
5%
Obstructive Sleep Apnea
5%
Triflusal
5%
Warfarin
5%
Rivaroxaban
5%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Ischemia
50%
Cerebrovascular Accident
33%
Brain Ischemia
19%
Atrial Fibrillation
18%
Brain Hemorrhage
15%
Atrial Fibrillation
10%
Clopidogrel
10%
Cilostazol
8%
Atherosclerosis
7%
Acetylsalicylic Acid
7%
Anticoagulant Agent
7%
CYP2C19
7%
Alteplase
7%
Infarction
7%
Randomized Clinical Trial
7%
D Dimer
6%
Brain Infarction
6%
Stenosis
5%
Biological Marker
5%
Group Trial
5%
Randomized Controlled Trial
5%
Triflusal
5%
Apolipoprotein B
5%
Cigarette Smoking
5%
Rivaroxaban
5%
Drug Surveillance
5%
Deterioration
5%
Rat Model
5%
Dimer
5%
Warfarin
5%
Controlled Clinical Trial
5%
Sleep Disordered Breathing
5%